000 01321 a2200373 4500
005 20250511174832.0
264 0 _c19930107
008 199301s 0 0 eng d
022 _a0160-2446
024 7 _a10.1097/00005344-199210000-00018
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSharif, M N
245 0 0 _aDiltiazem potentiates angiotensin II-mediated renal prostacyclin synthesis.
_h[electronic resource]
260 _bJournal of cardiovascular pharmacology
_cOct 1992
300 _a638-42 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a6-Ketoprostaglandin F1 alpha
_xurine
650 0 4 _aAngiotensin II
_xphysiology
650 0 4 _aAnimals
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aDiltiazem
_xpharmacology
650 0 4 _aEpoprostenol
_xbiosynthesis
650 0 4 _aKidney
_xdrug effects
650 0 4 _aMale
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aUrodynamics
_xdrug effects
650 0 4 _ap-Aminohippuric Acid
_xmetabolism
700 1 _aKaushal, R D
700 1 _aIyer, P
700 1 _aWilson, T W
773 0 _tJournal of cardiovascular pharmacology
_gvol. 20
_gno. 4
_gp. 638-42
856 4 0 _uhttps://doi.org/10.1097/00005344-199210000-00018
_zAvailable from publisher's website
999 _c1287252
_d1287252